Lynne Denny

Two Novel and Selective Nonimidazole Histamine H3 Receptor Antagonists A-304121 and A-317920: I. In Vitro Pharmacological Effects

Timothy A. Esbenshade, Kathleen M. Krueger, Thomas R. Miller et al. · Journal of Pharmacology and Experimental Therapeutics · 2003 · 102 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +13

Pharmacological Properties of ABT-239 [4-(2-{2-[(2 R)-2-Methylpyrrolidinyl]ethyl}-benzofuran-5-yl)benzonitrile]: I. Potent and Selective Histamine H3 Receptor Antagonist with Drug-Like Properties

Timothy A. Esbenshade, Gerard B. Fox, Kathleen M. Krueger et al. · Journal of Pharmacology and Experimental Therapeutics · 2005 · 100 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +13

Pharmacological and behavioral properties of A-349821, a selective and potent human histamine H3 receptor antagonist

Timothy A. Esbenshade, Gerard B. Fox, Kathleen M. Krueger et al. · Biochemical Pharmacology · 2004 · 68 citations

Medicine, Medicinal Chemistry, Pharmacology +8

Discovery and pharmacological characterization of aryl piperazine and piperidine ethers as dual acting norepinephrine reuptake inhibitors and 5-HT1A partial agonists

David Gray, Wenjian Xu, Brian Campbell et al. · Bioorganic & Medicinal Chemistry Letters · 2009 · 15 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +12

Synthesis and pharmacological evaluation of aminopyrimidine series of 5-HT1A partial agonists

Amy B. Dounay, Nancy S. Barta, Jack Bikker et al. · Bioorganic & Medicinal Chemistry Letters · 2008 · 12 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +11